Virus-induced immunosuppression is linked to rapidly fatal disease in infant rhesus macaques infected with simian immunodeficiency virus

被引:21
作者
Otsyula, MG
Miller, CJ
Marthas, ML
VanRompay, KKA
Collins, JR
Pedersen, NC
McChesney, MB
机构
[1] UNIV CALIF DAVIS,CALIF REG PRIMATE RES CTR,DAVIS,CA 95616
[2] UNIV CALIF DAVIS,DEPT PATHOL MICROBIOL & IMMUNOL,DAVIS,CA 95616
[3] UNIV CALIF DAVIS,DEPT MED & EPIDEMIOL,DAVIS,CA 95616
[4] UNIV CALIF DAVIS,SCH VET MED,DAVIS,CA 95616
[5] UNIV CALIF DAVIS,SCH MED,DEPT PATHOL,DAVIS,CA 95616
关键词
D O I
10.1203/00006450-199604000-00012
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Six newborn rhesus macaques were experimentally infected with pathogenic Simian immunodeficiency virus of macaques (SIVmac251), and three newborn macaques were infected with avirulent SIVmac1A11. The former developed rapidly fatal simian AIDS and died within 26 wk of age, whereas the latter remained clinically normal. Infant monkeys that developed rapidly progressive disease had rapid declines in CD4(+) cells and were unable to mount IgG and IgA antibody responses to SIV or to an unrelated antigen, tetanus toxoid. IgM antibody responses were near normal to both SIV-specific and nonspecific antigens. Cytotoxic T lymphocyte (CTL) responses to SN envelope were observed in animals infected with either virulent or avirulent SIV. These studies demonstrated that virulent SIVmac infection induced a rapid immunosuppression that was both SIV-specific and nonspecific in nature. The observation that virulent strains of SIV can rapidly induce a global immunosuppression provides one explanation for the rapid disease course in some HIV-infected children and supports the strategy of early and vigorous antiviral drug therapy to alter the disease course even if this does not prevent infection.
引用
收藏
页码:630 / 635
页数:6
相关论文
共 34 条
[1]   INCUBATION PERIODS FOR PEDIATRIC AIDS PATIENTS [J].
AUGER, I ;
THOMAS, P ;
DEGRUTTOLA, V ;
MORSE, D ;
MOORE, D ;
WILLIAMS, R ;
TRUMAN, B ;
LAWRENCE, CE .
NATURE, 1988, 336 (6199) :575-577
[2]  
BERNSTEIN LJ, 1986, PROG ALLERGY, V37, P194
[3]   DEFECTIVE HUMORAL IMMUNITY IN PEDIATRIC ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
BERNSTEIN, LJ ;
OCHS, HD ;
WEDGWOOD, RJ ;
RUBINSTEIN, A .
JOURNAL OF PEDIATRICS, 1985, 107 (03) :352-357
[4]   LONGITUDINAL-STUDY OF 94 SYMPTOMATIC INFANTS WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - EVIDENCE FOR A BIMODAL EXPRESSION OF CLINICAL AND BIOLOGICAL SYMPTOMS [J].
BLANCHE, S ;
TARDIEU, M ;
DULIEGE, AM ;
ROUZIOUX, C ;
LEDEIST, F ;
FUKUNAGA, K ;
CANIGLIA, M ;
JACOMET, C ;
MESSIAH, A ;
GRISCELLI, C .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (11) :1210-1215
[5]   THE EPIDEMIOLOGY OF HIV-INFECTION IN CHILDREN AND THEIR MOTHERS - VERTICAL TRANSMISSION [J].
BOYLAN, L ;
STEIN, ZA .
EPIDEMIOLOGIC REVIEWS, 1991, 13 :143-177
[6]  
BUSEYNE F, 1993, J IMMUNOL, V150, P3569
[7]  
CALLAHAN KM, 1993, J IMMUNOL, V151, P2928
[8]   CLINICAL AND LABORATORY CORRELATES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN CHILDREN INFECTED WITH HIV [J].
CONNOR, E ;
BAGARAZZI, M ;
MCSHERRY, G ;
HOLLAND, B ;
BOLAND, M ;
DENNY, T ;
OLESKE, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (13) :1693-1697
[9]  
Delfraissy J F, 1992, Immunodefic Rev, V3, P305
[10]   PROGNOSTIC-SIGNIFICANCE OF IMMUNOLOGICAL CHANGES IN 675 INFANTS PERINATALLY EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS [J].
DEMARTINO, M ;
TOVO, PA ;
GALLI, L ;
GABIANO, C ;
COZZANI, S ;
GOTTA, C ;
SCARLATTI, G ;
FIOCCHI, A ;
COCCHI, P ;
MARCHISIO, P ;
CANINO, R ;
MAUTONE, A ;
CHIAPPE, F ;
CAMPELLI, A ;
CONSOLINI, R ;
IZZI, G ;
LAVERDA, A ;
ALBERTI, S ;
TOZZI, AE ;
DUSE, M .
JOURNAL OF PEDIATRICS, 1991, 119 (05) :702-709